|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600126232 |
|
最近更新日期: Date of Last Refreshed on: |
2026-06-05 10:56:30 |
|
注册时间: Date of Registration: |
2026-06-05 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
中枢-外周闭环式磁刺激治疗脊髓损伤后神经源性膀胱疗效的临床研究 |
|
Public title: |
Clinical study of central-peripheral closed-loop magnetic stimulation in the treatment of neurogenic bladder after spinal cord injury |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
中枢-外周闭环式磁刺激治疗脊髓损伤后神经源性膀胱疗效的临床研究 |
|
Scientific title: |
Clinical study of central-peripheral closed-loop magnetic stimulation in the treatment of neurogenic bladder after spinal cord injury |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
李超 |
研究负责人: |
李超 |
|
Applicant: |
Li Chao |
Study leader: |
Li Chao |
|
申请注册联系人电话: Applicant telephone: |
+86 189 1909 0630 |
研究负责人电话:
Study leader's |
+86 189 1909 0630 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1335779645@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1335779645@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
甘肃省兰州市七里河区瓜州路418号(甘肃省中医院) |
研究负责人通讯地址: |
甘肃省兰州市七里河区瓜州路418号(甘肃省中医院) |
|
Applicant address: |
No.418, Guazhou Road, Qilihe District, Lanzhou City, Gansu Province ( Gansu Provincial Hospital of Traditional Chinese Medicine ) |
Study leader's address: |
No.418, Guazhou Road, Qilihe District, Lanzhou City, Gansu Province ( Gansu Provincial Hospital of Traditional Chinese Medicine ) |
|
申请注册联系人邮政编码: Applicant postcode: |
730050 |
研究负责人邮政编码: Study leader's postcode: |
730050 |
|
申请人所在单位: |
甘肃省中医院 |
||
|
Applicant's institution: |
Gansu Provincial Hospital of Traditional Chinese Medicine |
||
|
研究负责人所在单位: |
甘肃省中医院 |
||
|
Affiliation of the Leader: |
Gansu Provincial Hospital of Traditional Chinese Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2026-058-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
甘肃省中医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Gansu Provincial Hospital of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-03-25 00:00:00 | ||
|
伦理委员会联系人: |
李玉梅 |
||
|
Contact Name of the ethic committee: |
Li Yumei |
||
|
伦理委员会联系地址: |
甘肃省兰州市七里河区甘肃省中医院 |
||
|
Contact Address of the ethic committee: |
Gansu Provincial Hospital of Traditional Chinese Medicine, Qilihe District, Lanzhou City, Gansu Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 1391152952 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
甘肃省中医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Gansu Provincial Hospital of Traditional Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
甘肃省兰州市七里河区瓜州路418号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.418, Guazhou Road, Qilihe District, Lanzhou City, Gansu Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-financing |
||||||||||||||||||||||
|
研究疾病: |
脊髓损伤;神经源性膀胱 |
||||||||||||||||||||||
|
Target disease: |
Spinal cord injury ; neurogenic bladder |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
探讨中枢-外周闭环式磁刺激对脊髓损伤后神经源性膀胱的临床疗效与安全性。 |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate the clinical efficacy and safety of central-peripheral closed-loop magnetic stimulation on neurogenic bladder after spinal cord injury. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.符合《脊髓损伤神经学分类国际标准(2019版)》诊断,经CT/MRI证实,脊髓休克期已过; 2. 尿动力学确诊为逼尿肌无反射/低张力型神经源性膀胱,残余尿量>100 mL; 3.年龄18~65岁,ASIA分级B~D级; 4. 生命体征平稳,意识清楚,可配合治疗与评估; 5.签署知情同意书,本研究经医院伦理委员会批准。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.According to the International Standard for Neurological Classification of Spinal Cord Injury ( 2019 Edition ), the diagnosis was confirmed by CT / MRI, and the shock stage of spinal cord was over. 2.urodynamic diagnosis of detrusor areflexia / low tension neurogenic bladder, residual urine volume > 100 mL ; 3.18-65 years old, ASIA grade B-D ; 4.stable vital signs, clear consciousness, can cooperate with treatment and evaluation ; 5.signed the informed consent form, this study was approved by the hospital ethics committee. |
||||||||||||||||||||||
|
排除标准: |
1. 颅脑损伤、癫痫、颅内金属植入物、心脏起搏器; 2. 严重泌尿系感染、结石、尿道梗阻、肾功能不全; 3. 妊娠、认知障碍、精神疾病; 4. 近1个月接受过磁刺激或其他神经调控治疗。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.craniocerebral injury, epilepsy, intracranial metal implants, cardiac pacemaker ; 2. severe urinary tract infection, calculi, urethral obstruction, renal insufficiency ; 3. pregnancy, cognitive impairment, mental illness ; 4.Patients received magnetic stimulation or other neuromodulation therapy in the past 1 month. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-04-01 00:00:00至 To 2026-12-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-07-01 00:00:00 至 To 2026-09-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由未参与患者招募、评估与治疗的第三方统计人员,依据样本量使用SPSS22.0软件生成随机数字序列,将60例研究对象按1:1比例分为试验组与对照组,每组30例,从1开始到60编号,从随机数字表中任一行任一列开始,依次读取两位数作为一份随机数录于编号下,然后将全部随机数从小到大编序号,将每个随机数对应序号登记在表,规定序号1-30为试验组,序号31-60为对照组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The third-party statisticians who did not participate in the recruitment, evaluation and treatment of patients used SPSS22.0 software to generate a random number sequence according to the sample size. The 60 subjects were divided into experimental group and control group according to the ratio of 1 : 1, with 30 cases in each group. From 1 to 60 numbers, starting from any column of any row in the random number table, two digits were read in turn as a random number, and then all random numbers were serialized from small to large. The corresponding serial number of each random number was registered in the table. The serial number 1-30 was the experimental group, and the serial number 31-60 was the control group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
本研究实施评估者单盲,分组信息对结局评估者保密,所有疗效指标由不知情的专职人员统一评定,以减少测量偏倚。 |
|
Blinding: |
In this study, the evaluator was single-blind, and the grouping information was confidential to the outcome evaluator. All efficacy indicators were evaluated by uninformed professionals to reduce measurement bias. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture, EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |